[Macroprolactinemia, a variety of hyperprolactinemia. Apropos of 5 cases]

V Recchi1, S Hieronimus, G Creisson

  • 1Service d'endocrinologie, hôpital Pasteur, CHU, Nice, France.

La Revue De Medecine Interne
|January 1, 1997
PubMed

Insights

Macroprolactinemia, characterized by high levels of large prolactin variants, often presents as clinically insignificant hyperprolactinemia. Diagnosis relies on chromatography to distinguish these variants from biologically active prolactin.

Area of Science:

  • Endocrinology
  • Clinical Biochemistry

Background:

  • Macroprolactinemia involves elevated circulating levels of large molecular weight prolactin variants.
  • These big prolactin forms exhibit significantly reduced biological activity compared to monomeric prolactin.
  • This condition can lead to misdiagnosis of clinically significant hyperprolactinemia.

Observation:

  • Five patients presented with elevated immuno-reactive prolactin levels.
  • These elevated levels were attributed to macroprolactin, a large molecular weight variant of prolactin.
  • Macroprolactin demonstrated significantly weaker biological activity compared to monomeric prolactin.

Findings:

  • Macroprolactinemia results in elevated immuno-reactive prolactin levels due to the 'big' prolactin variants.
  • Despite high prolactin measurements, macroprolactinemia often lacks clinical significance due to the low bioactivity of these variants.
  • Chromatography is essential for diagnosing macroprolactinemia by separating prolactin variants.

Implications:

  • Macroprolactinemia represents a diagnostic pitfall in the evaluation of hyperprolactinemia.
  • Accurate diagnosis through chromatographic methods prevents unnecessary investigations and treatments for patients with macroprolactinemia.
  • Understanding prolactin variants is crucial for correct endocrine disorder assessment.

Related Concept Videos

Adrenal Gland Disorders01:27

Adrenal Gland Disorders

Adrenal gland disorders manifest when the production of adrenal hormones deviates from the norm, resulting in either excessive or insufficient concentrations.
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists01:28

Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists

Prokinetic agents are specialized medications that stimulate gastrointestinal (GI) motility, promoting food movement through the GI tract. Dopamine, an inhibitory neurotransmitter, plays a significant role in this process, reducing GI motility and indirectly controlling the speed of digestion. Dopamine receptor antagonists, such as metoclopramide and domperidone, offer a unique advantage as prokinetic agents. By blocking the dopamine receptors, these drugs increase GI motility, improving food...
Major Hormones and Their Functions01:27

Major Hormones and Their Functions

Hormones, the biochemical messengers produced by endocrine glands, are pivotal in regulating bodily functions and maintaining homeostasis. Each hormone's balance is crucial; imbalances can lead to significant physiological disruptions. Major hormones include oxytocin, cortisol, epinephrine, estrogen, testosterone, thyroxine, growth hormone, insulin, and glucagon.
Oxytocin, produced in the hypothalamus and released by the pituitary gland, plays a role in social bonding, childbirth, and lactation.
Mitral Valve Prolapse I: Introduction01:27

Mitral Valve Prolapse I: Introduction

IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
Hyperthyroidism I: Introduction01:25

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...